These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7556227)

  • 1. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
    Nakao M; Tada M; Tsuchimori K; Uekata M
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):391-9. PubMed ID: 7556227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
    Nakao M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S32-7. PubMed ID: 7673612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.
    Iwahi T; Satoh H; Nakao M; Iwasaki T; Yamazaki T; Kubo K; Tamura T; Imada A
    Antimicrob Agents Chemother; 1991 Mar; 35(3):490-6. PubMed ID: 2039199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
    Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
    Midolo PD; Turnidge JD; Lambert JR; Bell JM
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1531-3. PubMed ID: 8726032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
    Nakao M; Malfertheiner P
    Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
    Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
    Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro.
    Vogt K; Hahn H
    Arzneimittelforschung; 1998 Jun; 48(6):694-7. PubMed ID: 9689430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.
    Alarcón T; Domingo D; Sánchez I; Sanz JC; Martínez MJ; López-Brea M
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):275-7. PubMed ID: 9707312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro.
    Midolo PD; Turnidge JD; Lambert JR
    J Antimicrob Chemother; 1997 Mar; 39(3):331-7. PubMed ID: 9096182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
    [No Abstract]   [Full Text] [Related]  

  • 12. Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method.
    Fera MT; Carbone M; De Sarro A; Blandino G; Riggio G; Cusumano V; De Sarro GB; Ciliberti FA
    Int J Antimicrob Agents; 1998 Nov; 10(4):285-9. PubMed ID: 9916902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined activity of azithromycin and lansoprazole against Helicobacter pylori.
    Trautmann M; Riediger C; Möricke A; Vogt K; Bohr U; Glasbrenner B
    Helicobacter; 1999 Jun; 4(2):113-20. PubMed ID: 10382125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
    Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of Helicobacter pylori.
    Kawakami Y; Akahane T; Yamaguchi M; Oana K; Takahashi Y; Okimura Y; Okabe T; Gotoh A; Katsuyama T
    Antimicrob Agents Chemother; 2000 Feb; 44(2):458-61. PubMed ID: 10639386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
    Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
    World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of lansoprazole against Helicobacter pylori.
    Figura N; Crabtree JE; Dattilo M
    J Antimicrob Chemother; 1997 May; 39(5):585-90. PubMed ID: 9184356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth.
    Nakajima N; Kuwayama H; Iwasaki A; Arakawa Y
    J Clin Gastroenterol; 1995; 20 Suppl 2():S90-2. PubMed ID: 7594352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Helicobacter pylori infection: is less more?
    Howden CW
    J Clin Gastroenterol; 2000 Sep; 31(2):105-6. PubMed ID: 10993423
    [No Abstract]   [Full Text] [Related]  

  • 20. Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients.
    Shimoyama T; Munakata A; Mizuki I; Akagi T; Fukuda S; Ohkawa K; Yoshida Y; Aisawa T; Sakata Y; Fukushi M
    J Clin Gastroenterol; 1995; 20 Suppl 2():S125-7. PubMed ID: 7594328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.